The treatment of many human epileptic syndromes remains unsatisfactory. While anticonvulsant medications allow about 75% of epileptics to achieve excellent seizure control, the remaining 25% of patients suffer from a combination of continued seizures and medication toxicity. It is unlikely that a single medical breakthrough will provide a cure for all of these refractory patients. Focal neocortical epilepsies have proven particularly difficult to manage. While some respond to anticonvulsants, a large fraction remains intractable to medical therapy. This group can respond to cortical resection, but surgical management is problematic. Exact identification of the epileptogenic focus can be complicated and there is a risk of unanticipated, irreversible neurological deficits after resection. Focal cortical cooling has the potential to improve the evaluation and treatment of this epileptic subgroup.
The aims of the experiments described in this application are to investigate the potential of focal cooling with thermoelectric (Peltier) chips to rapidly terminate chronic seizure discharges, determine the degree of cooling required to stop these seizures, determine whether cooling can prevent seizures, and develop computer programs that recognize and anticipate seizures in """"""""real time"""""""". In addition, the potential pathological consequences of cortical cooling will be determined. These experiments represent a necessary first step toward utilizing these techniques for the therapy of human epilepsy. These experiments will utilize models of acute and chronic rodent neocortical seizures and small Peltier devices developed for the microelectronics industry. If Peltier devices can control focal seizures in our models, they will be refined for future experiments to investigate their potential role in mapping and controlling epileptogenic neocortex in man. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
7R01NS042936-06
Application #
7489554
Study Section
Special Emphasis Panel (ZRG1-BDCN-1 (01))
Program Officer
Fureman, Brandy E
Project Start
2003-04-01
Project End
2009-03-31
Budget Start
2007-07-17
Budget End
2009-03-31
Support Year
6
Fiscal Year
2007
Total Cost
$197,370
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Pediatrics
Type
Schools of Medicine
DUNS #
555917996
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Smyth, Matthew D; Han, Rowland H; Yarbrough, Chester K et al. (2015) Temperatures achieved in human and canine neocortex during intraoperative passive or active focal cooling. Ther Hypothermia Temp Manag 5:95-103
D'Ambrosio, Raimondo; Eastman, Clifford L; Darvas, Felix et al. (2013) Mild passive focal cooling prevents epileptic seizures after head injury in rats. Ann Neurol 73:199-209
Smyth, Matthew D; Rothman, Steven M (2011) Focal cooling devices for the surgical treatment of epilepsy. Neurosurg Clin N Am 22:533-46, vii
Yang, Xiao-Feng; Schmidt, Brigitte F; Rode, Daniel L et al. (2010) Optical suppression of experimental seizures in rat brain slices. Epilepsia 51:127-35
Rothman, Steven M (2009) The therapeutic potential of focal cooling for neocortical epilepsy. Neurotherapeutics 6:251-7
Yang, Xiao-Feng; Rothman, Steven M (2009) Levetiracetam has a time- and stimulation-dependent effect on synaptic transmission. Seizure 18:615-9
Xu, Lin; Rensing, Nicholas; Yang, Xiao-Feng et al. (2008) Leptin inhibits 4-aminopyridine- and pentylenetetrazole-induced seizures and AMPAR-mediated synaptic transmission in rodents. J Clin Invest 118:272-80
Rothman, Steven M; Perry, Gavin; Yang, Xiao-Feng et al. (2007) Optical suppression of seizure-like activity with an LED. Epilepsy Res 74:201-9
Zeng, Ling-Hui; Xu, Lin; Rensing, Nicholas R et al. (2007) Kainate seizures cause acute dendritic injury and actin depolymerization in vivo. J Neurosci 27:11604-13
Yang, Xiao-Feng; Weisenfeld, Aryan; Rothman, Steven M (2007) Prolonged exposure to levetiracetam reveals a presynaptic effect on neurotransmission. Epilepsia 48:1861-9

Showing the most recent 10 out of 17 publications